Introduction
============

Leptin produced by adipose tissue controls the hypothalamic regulation of appetite and energy consumption[@B1] and is also believed to affect reproductive function. This latter idea is based on the observations that activation of the hypothalamic-pituitary-gonadal (HPG) axis depends on sufficient body energy stores[@B2] and that prolonged negative energy balance can delay or prevent pubertal onset and cause reproductive dysfunction[@B2],[@B3]. The most definitive evidence for the link between leptin and the reproductive axis is that *ob/ob* mice and *db/db* mice are infertile[@B1],[@B4], and that exogenous leptin restores fertility in *ob/ob* mice.

Although an appropriate leptin level is important for pubertal onset and maintenance of reproduction, high levels of leptin may downregulate GnRH release. One *in vitro* study showed that exposure of hypothalamic tissues to high leptin concentration inhibits and GnRH secretion[@B5]. Female transgenic skinny mice overexpressing leptin have late-onset hypothalamic hypogonadism[@B6]. Leptin also has inhibitory effects on estradiol production in the ovary[@B7],[@B8], but studies investigating the role of excessive leptin on the HPG axis are limited.

Reports that GnRH neurons do not physiologically express the leptin receptors suggest the existence of an intermediate pathway between leptin and GnRH[@B9]-[@B11]. Kisspeptins, products of the *KiSS-1* gene, are regarded as key suspects. The *KiSS-1* gene is expressed mainly by the arcuate nucleus and anteroventral periventricular nucleus (AVPV) of the hypothalamus, and their G-protein-coupled receptor KiSS-1R has been identified in the hypothalamus and pituitary gland[@B12],[@B13]. Hypothalamic *KiSS-1* mRNA and *KiSS-1R* mRNA expression increase with the initiation of puberty in both male and female rats[@B14]. Intraventricular injection of kisspeptin to adult rats increases plasma LH level, and this response is blocked by a GnRH antagonist, suggesting that kisspeptin acts on the gonadotropic axis via GnRH[@B15]. *KiSS-1* expression is known to be controlled by metabolic status. Leptin is suspected to be a metabolic control factor of the KiSS-1 system.

The present experiments were performed to determine the effect of centrally injected leptin on the gene expression of hypothalamic *KiSS-1* and *GnRH* and pituitary LH in the pubertal state and to determine whether leptin controls *KiSS-1* or *GnRH* gene independently. To address these issues, we analyzed the effect of centrally injected leptin with or without a GnRH antagonist on *KiSS-1* and *GnRH* gene expression.

Materials and methods
=====================

1. Animals and drugs
--------------------

Female Imprinting Control Region mice in the 4th and 5th postnatal weeks were obtained from Dae Han Biolink Co. (Seoul, Korea). The mice were housed five per cage in a room maintained at 22±2℃ with an alternating 12/12-hour light/dark cycle. Food and water were available *ad libitum*. The experimental procedures were approved by the Institutional Animal Care and Use Committee of Kangwon National University. Recombinant mouse leptin (\>98% pure) was purchased from Biodesign International, Meridian Life Science, Inc. (Memphis, TN, USA). We used cetrorelix acetate (Merck Serono S.A., Geneva, Switzerland) as the GnRH antagonist.

2. Intracerebroventricular (ICV) injection
------------------------------------------

Leptin was injected into the lateral ventricle according to a procedure described previously by Laursen and Belknap[@B16]. The ICV injection volume was 5 µL, and control mice were administered the same volume of saline.

3. Experimental design
----------------------

We defined the pubertal sign in female mice as the existence of a vaginal opening. Pubertal mice (postnatal day 35 to 37) were assigned to a leptin or a control group. We injected 1 µg of leptin suspended in 5 µL of saline into the lateral ventricle of mice at 1:00 p.m. and the same volume of saline in the control group.

To block the action of GnRH, the GnRH antagonist cetrorelix (10 µg) was injected intraperitoneal 48, 24, and 1 hour before the ICV injection of either leptin or saline. Cetrorelix dose and injection interval were modified from a previous report[@B17].

The responses were observed 2 and 4 hours after the ICV leptin or saline injection. Mice were anesthetized with pentobarbital and killed by decapitation. The brains were removed and placed in 0.05 M phosphate buffer treated with diethylpyrocarbonate. Pituitary glands were collected, and whole hypothalamic tissues including preoptic area were taken from 3-mm coronal sections caudal to the bregma using a Vibratome R brain matrix device (Ted Pella, Redding, CA, USA). The hypothalamic section size was determined based on the histology atlas of Paxinos and Franklin[@B18].

We compared the mRNA expression of *KiSS-1*, *GnRH*, and *LH* between four groups (n=7 per subgroup): 1) ICV saline, 2) ICV leptin, 3) cetrorelix+ICV saline, and 4) cetrorelix+ICV leptin.

4. Analysis of mRNA expression by real-time polymerase chain reaction (PCR)
---------------------------------------------------------------------------

Total RNA was isolated from the hypothalamic and pituitary samples using the Easy-Spin Total RNA Extraction kit (INTRON Biotechnology Inc., Seongnam, Korea), and cDNA was synthesized from 2 µg of total RNA using OmniScript Reverse Transcriptase (QIAGEN Inc., Valencia, CA, USA). Hypothalamic expression of *KiSS-1* and *GnRH* mRNA, and pituitary expression of *LH* mRNA were assessed by real-time PCR using the ABI Prism 7900 System (Applied Biosystems Inc., Foster City, CA, USA). The synthesized cDNAs were amplified further in triplicate by PCR using SYBR green I as the fluorescent dye.

To verify the changes in gene expression, real-time PCR was performed on the experimental samples using the Sequence Detection System ver. 2.2 (Applied Biosystems Inc.). The CT for each sample was calculated using the Applied Biosystems Sequence Detection System ver. 2.2 software. Primer sets for mouse *KiSS-1*, *GNRH1*, and *Lhb* used in this study are provided in [Table 1](#T1){ref-type="table"}.

Relative expression levels of the target mRNAs were calculated using the standard curve method. The amount of mRNA was obtained from the standard curve and then normalized to the expression of glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which is a house-keeping gene used as an internal control. The expression ratio of the target gene relative to the control was obtained by dividing the experimental sample value corrected for GAPDH by the control sample value corrected for GAPDH.

5. Statistical analysis
-----------------------

All values are expressed as mean±standard error. Statistical analysis was performed using IBM SPSS ver. 18.0 (IBM Co., Armonk, NY, USA). Changes in the expression of the *KiSS-1*, *GnRH*, and *LH* genes at puberty and the effects of leptin or the GnRH antagonist on the expression of these genes were assessed by Mann-Whitney *U*-test. *P*\<0.05 was considered significant.

Results
=======

1. Comparison of gene expression between pubertal and prepubertal mice
----------------------------------------------------------------------

The gene expression levels of *KiSS-1*, *GnRH*, and *LH* were significantly higher in pubertal mice than in prepubertal mice in the basal state. Compared with the prepubertal mice, pubertal mice showed the following elevations in relative gene expression: 1.61-fold of *KiSS-1* (pubertal/prepubertal, 1.14/0.71; *P*=0.007), 1.98-fold of *GnRH* (pubertal/prepubertal, 1.07/0.54; *P*=0.000), and 38.21-fold of *LH* (pubertal/prepubertal, 14.90/0.39; *P*=0.000) ([Fig. 1](#F1){ref-type="fig"}).

2. Gene expression response to leptin
-------------------------------------

The experiments were performed with pubertal mice, which have an activated HPG axis and elevated target gene expression. Because the expression of each gene peaks at a different time, the responses were observed 2 and 4 hours after the ICV injection. The expression of the genes at each time was compared with that in the control at the same time to avoid the effects caused by diurnal variations.

Leptin-injected mice had significantly reduced expression of *KiSS-1*, *GnRH*, and *LH* mRNA compared with those of the control. The ratios of the *KiSS-1* mRNA expression in the leptin group relative to that in the control group were 0.23 at 2 hours (*P*=0.000) ([Fig. 2A](#F2){ref-type="fig"}) and 0.52 at 4 hours (*P*=0.000) ([Fig. 2B](#F2){ref-type="fig"}). The corresponding ratios for the GnRH gene were 0.37 at 2 hours (*P*=0.000) ([Fig. 3A](#F3){ref-type="fig"}) and 0.53 at 4 hours (*P*=0.000) ([Fig. 3B](#F3){ref-type="fig"}). The corresponding ratios for the LH gene were 0.36 at 2 hours (*P*=0.274) ([Fig. 4A](#F4){ref-type="fig"}) and 0.04 at 4 hours (*P*=0.000) ([Fig. 4B](#F4){ref-type="fig"}).

3. Gene expression response to the GnRH antagonist
--------------------------------------------------

Mice administered the GnRH antagonist had significantly increased *KiSS-1* and *GnRH* mRNA expression compared with those of the control. The ratios of the *KiSS-1* mRNA expression in the cetrorelix group relative to that in the control group were 1.18 at 2 hours (*P*=0.940) ([Fig. 2A](#F2){ref-type="fig"}) and 2.76 at 4 hours (*P*=0.000) ([Fig. 2B](#F2){ref-type="fig"}). The corresponding ratios for the *GnRH* gene were 1.62 at 2 hours (*P*=0.092) ([Fig. 3A](#F3){ref-type="fig"}) and 1.97 at 4 hours (*P*=0.005) ([Fig. 3B](#F3){ref-type="fig"}). The GnRH antagonist significantly blocked *LH* mRNA expression. The corresponding ratios for the *LH* gene were 0.0095 at 2 hours (*P*=0.000) ([Fig. 4A](#F4){ref-type="fig"}) and 0.0025 at 4 hours (*P*=0.000) ([Fig. 4B](#F4){ref-type="fig"}).

4. Gene expression response to the GnRH antagonist plus leptin
--------------------------------------------------------------

*KiSS-1* and *GnRH mRNA* expression decreased significantly in the cetrorelix plus leptin group compared with that in either the cetrorelix group or the control. The ratios of the *KiSS-1* mRNA expression in the cetrorelix plus leptin group relative to that in the cetrorelix group were 0.11 at 2 hours (0.13/1.18, *P*=0.000) ([Fig. 2A](#F2){ref-type="fig"}) and 0.30 at 4 hours (0.85/2.76, *P*=0.000) ([Fig. 2B](#F2){ref-type="fig"}). The corresponding ratios for the *GnRH* gene were 0.14 at 2 hours (0.23/1.62, *P*=0.000) ([Fig. 3A](#F3){ref-type="fig"}) and 0.45 at 4 hours (0.89/1.97, *P*=0.007) ([Fig. 3B](#F3){ref-type="fig"}). The *LH* mRNA expression decreased further in the cetrorelix plus leptin group, and the corresponding ratios were 0.31 at 2 hours (0.0029/0.0095, *P*=0.000) ([Fig. 4A](#F4){ref-type="fig"}) and 0.80 at 4 hours (0.0020/0.0025, *P*=0.359) ([Fig. 4B](#F4){ref-type="fig"}).

Compared with the control group, the ratios were 0.13 at 2 hours (*P*=0.000) ([Fig. 2A](#F2){ref-type="fig"}) and 0.85 at 4 hours (*P*=0.176) ([Fig. 2B](#F2){ref-type="fig"}) for the *KiSS-1* gene, 0.23 at 2 hours (*P*=0.000) ([Fig. 3A](#F3){ref-type="fig"}) and 0.89 at 4 hours (*P*=0.159) ([Fig. 3B](#F3){ref-type="fig"}) for the *GnRH* gene, and 0.0029 at 2 hours (*P*=0.000) ([Fig. 4A](#F4){ref-type="fig"}) and 0.0020 at 4 hours (*P*=0.000) ([Fig. 4B](#F4){ref-type="fig"}) for the *LH* gene.

Discussion
==========

Our results show that central injection of 1 µg leptin has a suppressive effect on *KiSS-1*, *GnRH*, and *LH* gene expression related to reproductive axis in pubertal female mice. We were interested in the direct effect of leptin on the expression of these genes, so leptin was administered via a central route. The acute administration of leptin directly into the ventricle might expose the brain to higher concentrations than are physiologically normal, and high level of leptin might suppress the expression of hypothalamic *KiSS-1* and *GnRH* mRNAs and pituitary *LH* mRNA in normal pubertal mice.

Previous studies have shown that leptin is a permissive factor for puberty and plays a role in maintaining reproductive function. It is believed that there is a threshold level of circulating leptin to enter the puberty and leptin threshold of -3 ng/mL is necessary for normal reproductive function in human[@B19]. Leptin-deficient conditions are associated with reproductive dysfunction. Although the concept that leptin stimulates the hypothalamic-pituitary reproductive axis is prevalent, some reports have suggested that leptin also has a suppressive effect on the reproductive axis under conditions of leptin excess[@B5],[@B6],[@B20],[@B21].

When hypothalamic and pituitary tissues were exposed to various concentrations of leptin *in vitro*, the increase in LH secretion that is observed at lower leptin concentrations (10^-12^ to 10^-9^ M) was not observed at higher concentrations (10^-7^ to 10^-5^ M), and GnRH secretion decreased below the control level at the highest leptin concentration (10^-6^ M)[@B5]. Female transgenic skinny mice that overexpress leptin exhibit accelerated puberty and late-onset hypothalamic hypogonadism, characterized by prolonged menstrual cycles, atrophied ovaries, reduced hypothalamic GnRH content, and an impaired spontaneous LH pulse or a weak LH response to exogenous GnRH[@B6]. Although the mechanism of the suppressive effect of excessive leptin on reproductive axis has not be studied yet, these results suggest that excessive leptin downregulates the signal transmission in the hypothalamus and suppresses the central reproductive axis. Recent evidence suggests that leptin acts upstream of *KiSS-1* neurons and this effect may be indirect[@B22],[@B23]. We also suggest that the suppressive action of excessive leptin is upstream of KiSS-1 and GnRH neurons, but the mechanism of inhibitory signal should be further investigated.

Clinical conditions associated with hyperleptinemia are obesity, renal failure, and the cases using supraphysiological dose of leptin for therapeutic purposes. Women with obesity have low serum gonadotropin and estrogen levels and decreased LH secretion in response to exogenous GnRH[@B20]. Female DBA/2J mice with diet-induced obesity showed hyperleptinemia, and the pregnancy rate decreased by more than 60% but was normalized after stimulation with exogenous gonadotropin[@B21]. The prevalent view is that the dysfunction of the central reproductive axis in obesity is caused by leptin resistance. However, the direct effect of excessive leptin in obesity on the HPG axis needs to be investigated in further studies. Leptin has inhibitory effects on estradiol production in the ovary[@B7],[@B8].

Recent studies demonstrating that treatment of leptin enhances LH secretion and *KiSS-1* mRNA expression were conducted mainly in adult mice or rats with hypoleptinemia and defective reproductive function. Leptin administered into the ventricles of adult male rats fasted for 5 days increased the blood LH level compared with the level in a control group[@B24]. In streptozotocin-induced diabetic rats, central infusion of leptin significantly increased blood LH level and hypothalamic *KiSS-1* mRNA expression[@B25]. Peripheral administration of leptin into *ob/ob* mice recovers the defective *KiSS-1* mRNA expression to some degree[@B26]. We carried out the experiment for female mice which weighed 19 to 22 g on normal diets and showed vaginal opening in time, so they are suspected to have normal physiology of leptin. The ICV injection of leptin to normal pubertal mice could be regarded as the condition of leptin excess.

Yu et al.[@B5] also conducted an *in vivo* experiment for normal adult Sprague-Dawley rat and showed that the administration of 10 µg of human leptin into the 3rd ventricle increased plasma LH level in 10 to 50 minutes. Our study is similar to this study in experimental design, but the results are opposite. The different points are as follows. There is timing difference in tissue or blood sampling. We checked the gene expression in 2 and 4 hours observe a persisting effect, for we could not get the consistent results for immediate response (within 30 minutes) after leptin administration in preliminary experiments. Considering that we used mouse leptin and the cerebrospinal fluid volume of a mouse is 10- to 20-fold less than that of a rat an, 1 µg of mouse leptin in a pubertal mouse might act on the brain tissue more strongly than 10 µg of human leptin in a adult rat.

Becuase GnRH neurons do not express the leptin receptor under physiological conditions, GnRH neurons are regulated by leptin indirectly[@B9]-[@B11]. Recent evidence suggests that leptin may mediate the reproductive axis by regulation of kisspeptins. In our study, the decreased *GnRH* expression caused by leptin administration might have resulted from the suppression of *KiSS-1* gene expression.

KiSS-1 neurons express the estrogen receptor-α (ERα), which is involved in feedback control[@B27]. Estradiol can inhibit the KiSS-1 neurons located in the arcuate nucleus[@B28],[@B29], but estradiol activates *KiSS-1* in AVPV[@B28]. We administered a GnRH antagonist to observe the feedback effect of low estradiol concentration and to eliminate the effect of estradiol induced by GnRH/LH. As expected, the GnRH antagonist effectively blocked *LH* mRNA expression. The GnRH antagonist itself increased *KiSS-1* and *GnRH* mRNA expression. Because GnRH neurons lack the ERα[@B29], the increase in *GnRH* mRNA level is probably caused by both an indirect effect that is dependent of *KiSS-1* and an ultrashort-loop autocrine feedback mechanism[@B30].

The observation that the stimulation of *KiSS-1* and *GnRH* mRNA expression by the GnRH antagonist was suppressed by leptin suggests that leptin inhibits the of *KiSS-1* expression regardless of feedback control. *LH* mRNA expression blocked by a GnRH antagonist was further reduced by leptin. This suggests that there was an indirect regulation or an effect secondary to changes in hypothalamic gene expression.

In summary, we demonstrated that supraphysiologic level of leptin in normal pubertal female mice suppresses the hypothalamicpituitary reproductive axis by inhibiting the expression of the *KiSS-1* gene, and that this action is independent of the GnRH-LH-estradiol feedback loop.

This study has several limitations. First, since the results show the acute and short-term effects of a single injection of leptin, it is difficult to link with the chronic or long-term effect. Second, the results can be confined to pubertal mice in which the HPG axis is initially activated. Third, if hormonal level would be checked at the same time of tissue collection, it would give more information about the clinical correlation. Fourth, a dose response curve for leptin or at least an examination of a lower leptin dose would strengthen the report.

In addition, we should consider more complex neuronal interactions among the nuclei in hypothalamus. Further studies are required not only to reveal the connection between leptin excess and reproductive dysfunction but also to discover underlying mechanisms. The present study is the experimental evidence for another aspect of leptin and represents a step forward in understanding the control of reproductive function.
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![Differences in gene expression levels between the prepubertal (gray columns) and pubertal mice (black columns) not treated with a specific drug. The values are means±standard error. ^\*^*P*\<0.01 versus prepubertal mice.](kjped-55-337-g001){#F1}

![Effects of leptin and the GnRH antagonist (cetrorelix) on the hypothalamic *KiSS-1* gene expression. (A) Gene expression levels 2 hours after intracerebroventricular (ICV) injection. (B) Gene expression levels 4 hours after ICV injection. The KiSS-1 mRNA expression level significantly decreased in the leptin group and increased in the cetrorelix group. The KiSS-1 mRNA expression level decreased significantly in the cetrorelix+leptin group as compared with the cetrorelix and control groups. The values are the means±standard error. ^\*^*P*\<0.01 versus the control group. ^\*\*^*P*\<0.01 versus the cetrorelix group.](kjped-55-337-g002){#F2}

![Effects of leptin and cetrorelix on hypothalamic *GnRH* gene expression. (A) The gene expression levels 2 hours after the intracerebroventricular (ICV) injection. (B) The gene expression levels 4 hours after ICV injection. The *GnRH* mRNA expression level significantly decreased in the leptin group and increased in the cetrorelix group. The *GnRH* mRNA expression level significantly decreased in the cetrorelix+leptin group compared with the cetrorelix and control groups. The values are means±standard error. ^\*^*P*\<0.01 versus the control group. ^\*\*^*P*\<0.01 versus the cetrorelix group.](kjped-55-337-g003){#F3}

![Effects of leptin and cetrorelix on pituitary *LH* gene expression. (A) Gene expression levels 2 hours after intracerebroventricular (ICV) injection. (B) Gene expression levels 4 hours after ICV injection. *LH* mRNA expression decreased significantly in the leptin group and in the cetrorelix group. *LH* mRNA expression decreased further in the cetrorelix+leptin group compared with the cetrorelix group. Values are means±standard error. ^\*^*P*\<0.01 vs. control group. ^\*\*^*P*\<0.01 vs. the cetrorelix group.](kjped-55-337-g004){#F4}
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Mouse-Specific Primer Sets for Amplification of Transcripts of KiSS-1, GNRH1, and Lhb Genes, Used for Real-Time Polymerase Chain Reaction
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